Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design.
Baroreflex activation therapy in heart failure - the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) trial rationale and design.
Sheikh FH, Abraham WT, Adamson PB, Anker SD, Brown S, Butler J, Friede T, Lindenfeld JA, Perez-Izquierdo M, Wilks SJ, Zannad F, Zile MR (2026). Journal of Cardiac Failure.
